Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts
Mycoses · 2026-01 · 69 (1)
DOI: 10.1111/myc.70139 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mycoses, online erschienen am 21.01.2026. Verfasst von A Apostolopoulou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Mycoses, Mycology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irma L. and Abram S. Croll Charitable Trust, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve outcomes. Key themes of the 2024 biennial meeting included emergence of antifungal resistance, the effects of climate change on incidence of IFI, recent healthcare‐and community‐associated outbreaks and their management, and the potential benefits of novel approaches, such as innovative study designs, host‐directed diagnostics and therapies, and artificial intelligence in clinical and academic mycology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, New York, USA.
- Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
- Section of Infectious Diseases and Public Health, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
ORCID-Profile: A Apostolopoulou, D Z P Friedman, I S Schwartz
Förderung
- Irma L. and Abram S. Croll Charitable Trust
- NIH HHS
- NIAID NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Apostolopoulou, A., Stewart, A. G., Yoon, H., Steinbrink, J. M., Friedman, D. Z. P., Ostrosky-Zeichner, L., Schwartz, I. S., & Mycoses Study Group Education and Research Consortium (MSGERC) (2026). Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts. Mycoses, 69(1). https://doi.org/10.1111/myc.70139
Vancouver
Apostolopoulou A, Stewart AG, Yoon H, Steinbrink JM, Friedman DZP, Ostrosky-Zeichner L, et al. Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts. Mycoses. 2026;69(1). doi:10.1111/myc.70139
BibTeX
@article{Apostolopoulou2026,
author = {Apostolopoulou, A and Stewart, A G and Yoon, H and Steinbrink, J M and Friedman, D Z P and Ostrosky-Zeichner, L and Schwartz, I S and Mycoses Study Group Education and Research Consortium (MSGERC), Mycoses Study Group Education and Research Consortium (MSGERC)},
title = {Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts},
journal = {Mycoses},
year = {2026},
volume = {69},
number = {1},
doi = {10.1111/myc.70139}
}
EUVIMED